journal article·2026-05-28Open access

Brown Adipocyte Sheets Alleviate Myocardial Ischemia–Reperfusion Injury Through NRG4–ErbB4–Dependent Ferroptosis Inhibition

Lifu Sun, Yuting Liu, Jingbo Zhang, Takuji Kawamura, Junjun Li, Li Liu, Shigeru Miyagawa

Abstract

ABSTRACT Myocardial ischemia–reperfusion (I/R) injury causes cardiomyocyte death and cardiac dysfunction in part through ferroptosis. Brown adipocytes (BAs) have emerged as endocrine regulators with cardioprotective potential, yet their involvement in ferroptosis modulation during I/R injury remains unclear. Here, we engineered BA sheets and transplanted them onto the ischemic myocardium in a rat I/R model to evaluate therapeutic efficacy. BA sheets transplantation significantly improved cardiac function, reduced infarct size and fibrosis, and mitigated adverse remodeling while enhancing angiogenesis. In vitro, conditioned medium derived from BA sheets promoted cardiomyocyte survival, preserved contractile performance, and inhibited apoptosis and ferroptosis under hypoxia/reoxygenation stress. Mechanistically, these effects were mediated by the activation of the NRG4–ErbB4 axis and its downstream PI3K/AKT and NRF2/HO‐1 antioxidant signaling pathways. Our findings demonstrate that engineered BA sheets exert potent cardioprotection against myocardial I/R injury by suppressing ferroptosis in an NRG4–ErbB4–dependent manner, supporting their promise as a therapeutic strategy for ischemic heart disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · GDF15 and Related Biomarkers · Adipose Tissue and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiovascular Surgery Graduate School of Medicine The University of Osaka Suita Osaka Japan

Photonics Cell Evaluation Laboratory Graduate School of Engineering The University of Osaka Suita Osaka Japan

References (53)

Show source-provided references
1. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics‐2021 Update: A Report From the American Heart Association10.1161/CIR.0000000000000950 ↗
2. 10.1186/s13287‐023‐03560‐910.1186/s13287‐023‐03560‐9 ↗
3. 10.1161/CIRCRESAHA.121.32071710.1161/CIRCRESAHA.121.320717 ↗
4. 10.1161/CIRCRESAHA.116.30534810.1161/CIRCRESAHA.116.305348 ↗
5. 10.1038/cdd.2011.9610.1038/cdd.2011.96 ↗
6. 10.1152/physrev.00022.201810.1152/physrev.00022.2018 ↗
7. 10.1016/j.tips.2017.02.00510.1016/j.tips.2017.02.005 ↗
8. 10.1161/CIRCULATIONAHA.122.06025710.1161/CIRCULATIONAHA.122.060257 ↗
9. 10.1016/j.tcb.2015.10.01410.1016/j.tcb.2015.10.014 ↗
10. 10.1007/s10571‐024‐01457‐610.1007/s10571‐024‐01457‐6 ↗
11. 10.1038/s41419‐022‐04628‐910.1038/s41419‐022‐04628‐9 ↗
12. Research Progress Of Ferroptosis In Acute Kidney Injury10.3389/fcell.2025.1614156 ↗
13. 10.1007/s11154‐023‐09850‐010.1007/s11154‐023‐09850‐0 ↗
14. 10.1016/j.cell.2015.02.02210.1016/j.cell.2015.02.022 ↗
15. 10.1161/CIRCRESAHA.121.32045810.1161/CIRCRESAHA.121.320458 ↗
16. 10.1007/s13679‐021‐00465‐710.1007/s13679‐021‐00465‐7 ↗
17. 10.1038/s41591‐020‐1126‐710.1038/s41591‐020‐1126‐7 ↗
18. A Novel Endocrine Role for the BAT‐Released Lipokine 12,13‐diHOME to Mediate Cardiac Function10.1161/CIRCULATIONAHA.120.049813 ↗
19. 10.1161/CIRCRESAHA.122.32233710.1161/CIRCRESAHA.122.322337 ↗
20. 10.1016/j.cmet.2018.06.01310.1016/j.cmet.2018.06.013 ↗
21. 10.1038/s41574‐019‐0230‐610.1038/s41574‐019‐0230‐6 ↗
22. 10.1161/CIRCRESAHA.121.32047010.1161/CIRCRESAHA.121.320470 ↗
23. Development Of Composite Functional Tissue Sheets Using hiPSC‐CMs and hADSCs to Improve The Cardiac Function After Myocardial Infarction
24. 10.1161/CIRCRESAHA.117.31206710.1161/CIRCRESAHA.117.312067 ↗
25. 10.1093/nar/gkn92310.1093/nar/gkn923 ↗
26. 10.1016/j.isci.2024.10899210.1016/j.isci.2024.108992 ↗
27. Angiogenesis Analyzer for ImageJ — A Comparative Morphometric Analysis of ″Endothelial Tube Formation Assay″ and ″Fibrin Bead Assay10.1038/s41598-020-67289-8 ↗
28. 10.1007/s42765‐023‐00313‐410.1007/s42765‐023‐00313‐4 ↗
29. 10.1016/j.healun.2023.01.01810.1016/j.healun.2023.01.018 ↗
30. 10.1038/nm.371310.1038/nm.3713 ↗
31. 10.1038/s42255‐022‐00671‐010.1038/s42255‐022‐00671‐0 ↗
32. 10.1186/s12933‐022‐01643‐010.1186/s12933‐022‐01643‐0 ↗
33. 10.1038/s41569‐020‐0403‐y10.1038/s41569‐020‐0403‐y ↗
34. 10.1016/j.tem.2023.10.01010.1016/j.tem.2023.10.010 ↗
35. 10.1016/j.tcm.2022.02.00510.1016/j.tcm.2022.02.005 ↗
36. 10.3892/ijmm.2024.543410.3892/ijmm.2024.5434 ↗
37. 10.1186/s12964‐024‐01853‐x10.1186/s12964‐024‐01853‐x ↗
38. 10.1002/advs.20231022710.1002/advs.202310227 ↗
39. 10.1016/S0002‐9149(03)00148‐610.1016/S0002‐9149(03)00148‐6 ↗
40. 10.1172/JCI12642810.1172/JCI126428 ↗
41. 10.1073/pnas.182102211610.1073/pnas.1821022116 ↗
42. 10.1161/CIRCRESAHA.120.31650910.1161/CIRCRESAHA.120.316509 ↗
43. 10.1056/NEJMra180021910.1056/NEJMra1800219 ↗
44. 10.1530/EJE‐20‐143910.1530/EJE‐20‐1439 ↗
45. 10.1016/j.hsr.2024.10014810.1016/j.hsr.2024.100148 ↗
46. 10.1016/j.metabol.2023.15570910.1016/j.metabol.2023.155709 ↗
47. 10.1152/ajpheart.01058.200910.1152/ajpheart.01058.2009 ↗
48. 10.1016/j.yexcr.2024.11419510.1016/j.yexcr.2024.114195 ↗
49. 10.1016/j.jep.2025.12015610.1016/j.jep.2025.120156 ↗
50. Pharmacological Activation of GPR68 Attenuates Ferroptosis in Spinal Cord Ischemia/Reperfusion Injury Through PI3K/Akt‐Mediated Nrf2 Antioxidant Pathway10.1007/s10753-025-02326-0 ↗
51. 10.1016/j.mtbio.2025.10187310.1016/j.mtbio.2025.101873 ↗
52. 10.1002/advs.20230556310.1002/advs.202305563 ↗
53. 10.15419/rshtry2110.15419/rshtry21 ↗